Population Genetics Technologies Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Population Genetics Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014063
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Population Genetics Technologies Ltd (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company provides products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assay kits that include access to cloud-based data analysis through a web interface used in delivery of clinical reports that interpret the sequencing data. The company’s HCV diagnostic test systems are used in mutation verification tagging HCV drug resistance diagnostic tests to target HCV genotypes and improve clinical diagnosis for HCV-infected patients. Population Genetics is headquartered in Cambridge, the UK.

Population Genetics Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Population Genetics Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Population Genetics Technologies Secures US$6 Million In Series B Financing 10
Partnerships 11
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 11
Licensing Agreements 12
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 12
Population Genetics Technologies Ltd – Key Competitors 13
Population Genetics Technologies Ltd – Key Employees 14
Population Genetics Technologies Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Population Genetics Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Population Genetics Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Population Genetics Technologies Secures US$6 Million In Series B Financing 10
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 11
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 12
Population Genetics Technologies Ltd, Key Competitors 13
Population Genetics Technologies Ltd, Key Employees 14

★海外企業調査レポート[Population Genetics Technologies Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ngai Hing Hong Co Ltd (1047)
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Explaurum Ltd (EXU):企業の財務・戦略的SWOT分析
    Summary Explaurum Ltd (Explaurum) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of precious and base metals deposits. It explores for copper, gold, silver, zinc, molybdenum, lead, tin, phosphates, aluminium, uranium and …
  • Banco de Sabadell, S.A.:戦略・SWOT・企業財務分析
    Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • Energy Development Corp (EDC):企業の財務・戦略的SWOT分析
    Energy Development Corp (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ABB Ltd (ABBN)-石油・ガス分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …
  • Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報
    Summary Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa …
  • Avantec Vascular Corp:企業の製品パイプライン分析2018
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd, is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gu …
  • Conco, Inc.:企業の戦略・SWOT・財務情報
    Conco, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary China National Petroleum Corporation (CNPC) is an integrated oil and gas company that produces and supplies oil and gas and petrochemical products. The company explores, develops and produces hydrocarbons in onshore and offshore areas of China, Canada, Africa, Central Asia and Russia, Latin …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務分析
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Michael J Fox Foundation for Parkinson’s Research:医療機器:M&Aディール及び事業提携情報
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments …
  • Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c an …
  • The Hokkaido Bank Ltd:企業の戦略・SWOT・財務情報
    The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Impresa Pizzarotti & C. S.p.A.:企業の戦略・SWOT・財務情報
    Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Origin Energy Ltd (ORG)-エネルギー分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆